不同生物工厂中重组蛋白生产的比较评估：绿色视角。
Comparative evaluation of recombinant protein production in different biofactories: the green perspective.
机构信息
Department of Biotechnology, University of Verona, 37134 Verona, Italy.
出版信息
Biomed Res Int. 2014;2014:136419. doi: 10.1155/2014/136419. Epub 2014 Mar 12.
Abstract
In recent years, the production of recombinant pharmaceutical proteins in heterologous systems has increased significantly. Most applications involve complex proteins and glycoproteins that are difficult to produce, thus promoting the development and improvement of a wide range of production platforms. No individual system is optimal for the production of all recombinant proteins, so the diversity of platforms based on plants offers a significant advantage. Here, we discuss the production of four recombinant pharmaceutical proteins using different platforms, highlighting from these examples the unique advantages of plant-based systems over traditional fermenter-based expression platforms.
摘要
近年来，异源系统中重组药物蛋白的生产显著增加。大多数应用涉及难以生产的复杂蛋白质和糖蛋白，从而促进了广泛的生产平台的发展和改进。没有一个单一的系统对所有重组蛋白的生产都是最优的，因此基于植物的平台多样性具有显著的优势。在这里，我们讨论了使用不同平台生产四种重组药物蛋白的情况，从这些例子中突出了植物基系统相对于传统发酵器表达平台的独特优势。
相似文献
1
Comparative evaluation of recombinant protein production in different biofactories: the green perspective.不同生物工厂中重组蛋白生产的比较评估：绿色视角。
Biomed Res Int. 2014;2014:136419. doi: 10.1155/2014/136419. Epub 2014 Mar 12.
2
Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment.植物生产的生物制药：技术发展推动临床应用的案例。
Science. 2016 Sep 16;353(6305):1237-40. doi: 10.1126/science.aaf6638.
3
Plant bioreactors for pharmaceuticals.用于药物的植物生物反应器。
Biotechnol Genet Eng Rev. 2008;25:363-80. doi: 10.5661/bger-25-363.
4
On risk and plant-based biopharmaceuticals.论风险与植物源生物制药
Trends Biotechnol. 2004 Feb;22(2):64-6. doi: 10.1016/j.tibtech.2003.11.007.
5
A comparative analysis of recombinant protein expression in different biofactories: bacteria, insect cells and plant systems.不同生物工厂中重组蛋白表达的比较分析：细菌、昆虫细胞和植物系统。
J Vis Exp. 2015 Mar 23(97):52459. doi: 10.3791/52459.
6
Molecular farming of human cytokines and blood products from plants: challenges in biosynthesis and detection of plant-produced recombinant proteins.植物中人类细胞因子和血液产品的分子农业生产：植物生产的重组蛋白生物合成和检测中的挑战。
Biotechnol J. 2014 Jan;9(1):39-50. doi: 10.1002/biot.201300062. Epub 2013 Dec 23.
7
Engineering the Plant Secretory Pathway for the Production of Next-Generation Pharmaceuticals.工程植物分泌途径生产新一代药物。
Trends Biotechnol. 2020 Sep;38(9):1034-1044. doi: 10.1016/j.tibtech.2020.03.004. Epub 2020 Apr 1.
8
[Plants as an alternative source of therapeutic proteins].[植物作为治疗性蛋白质的替代来源]
Postepy Hig Med Dosw (Online). 2015 Mar 22;69:362-73. doi: 10.5604/17322693.1145824.
9
Biopharmaceuticals from plants: a multitude of options for posttranslational modifications.植物来源的生物制药：多种翻译后修饰的选择。
Biotechnol Genet Eng Rev. 2008;25:315-30. doi: 10.5661/bger-25-315.
10
[Plant as bioreactor].[植物作为生物反应器]
Sheng Wu Gong Cheng Xue Bao. 2009 May;25(5):650-7.
引用本文的文献
1
An efficient lysate-based approach for biosynthesis of the pyrrolobenzodiazepine natural product tilimycin.一种基于裂解物的高效方法用于吡咯并苯二氮䓬天然产物替米卡星的生物合成。
J Biotechnol. 2025 Jun;402:87-95. doi: 10.1016/j.jbiotec.2025.03.012. Epub 2025 Mar 20.
2
Proteomic analysis reveals molecular changes following genetic engineering in Chlamydomonas reinhardtii.蛋白质组学分析揭示了衣藻基因工程后的分子变化。
BMC Microbiol. 2024 Oct 8;24(1):392. doi: 10.1186/s12866-024-03554-4.
3
High-yield, plant-based production of an antimicrobial peptide with potent activity in a mouse model.高效、植物源生产具有强大活性的抗菌肽，在小鼠模型中具有良好的效果。
Plant Biotechnol J. 2024 Dec;22(12):3392-3405. doi: 10.1111/pbi.14460. Epub 2024 Sep 12.
4
Development of Virus-like Particle Plant-Based Vaccines against Avian H5 and H9 Influenza A Viruses.针对甲型禽流感H5和H9病毒的基于植物的病毒样颗粒疫苗的研发
Vet Sci. 2024 Feb 18;11(2):93. doi: 10.3390/vetsci11020093.
5
A Review of Rattlesnake Venoms.响尾蛇毒液综述
Toxins (Basel). 2023 Dec 19;16(1):2. doi: 10.3390/toxins16010002.
6
Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness.基于植物的新冠疫苗作为大流行防范措施出现的紧迫性。
Vaccines (Basel). 2023 Aug 9;11(8):1347. doi: 10.3390/vaccines11081347.
7
Recombinant Proteins for Assembling as Nano- and Micro-Scale Materials for Drug Delivery: A Host Comparative Overview.用于组装成纳米和微米级药物递送材料的重组蛋白：宿主比较综述
Pharmaceutics. 2023 Apr 9;15(4):1197. doi: 10.3390/pharmaceutics15041197.
8
Optimising expression and extraction of recombinant proteins in plants.优化植物中重组蛋白的表达与提取
Front Plant Sci. 2022 Dec 8;13:1074531. doi: 10.3389/fpls.2022.1074531. eCollection 2022.
9
Immunoinformatic analysis of the whole proteome for vaccine design: An application to .基于全蛋白质组的免疫信息学分析用于疫苗设计：在 …… 中的应用
Front Immunol. 2022 Aug 30;13:942907. doi: 10.3389/fimmu.2022.942907. eCollection 2022.
10
An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives.对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的结构、发病机制、药物研发靶点探寻及疫苗研发进展的深入了解
RSC Med Chem. 2022 Jan 25;13(6):647-675. doi: 10.1039/d2md00009a. eCollection 2022 Jun 22.
本文引用的文献
1
Comparative analysis of different biofactories for the production of a major diabetes autoantigen.不同生物工厂生产主要糖尿病自身抗原的比较分析。
Transgenic Res. 2014 Apr;23(2):281-91. doi: 10.1007/s11248-013-9749-9. Epub 2013 Oct 20.
2
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.靶向白细胞介素-6 治疗炎症性自身免疫性疾病和癌症。
Pharmacol Ther. 2014 Feb;141(2):125-39. doi: 10.1016/j.pharmthera.2013.09.004. Epub 2013 Sep 27.
3
Interleukin-6 polymorphisms and hematologic malignancy: a re-appraisal of evidence from genetic association studies.白细胞介素 6 多态性与血液系统恶性肿瘤：遗传关联研究证据的再评价。
Biomarkers. 2013 Nov;18(7):625-31. doi: 10.3109/1354750X.2013.840799. Epub 2013 Sep 23.
4
The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications--a review.白细胞介素-6 在卵巢癌演进中的作用：临床和预后意义——综述。
J Mol Med (Berl). 2013 Dec;91(12):1355-68. doi: 10.1007/s00109-013-1080-7. Epub 2013 Sep 21.
5
Expression and assembly of Norwalk virus-like particles in plants using a viral RNA silencing suppressor gene.利用病毒 RNA 沉默抑制基因在植物中表达和组装诺如病毒样颗粒。
Appl Microbiol Biotechnol. 2013 Oct;97(20):9021-7. doi: 10.1007/s00253-013-5077-5. Epub 2013 Aug 8.
6
Oral delivery of therapeutic proteins and peptides: a review on recent developments.口服递送治疗性蛋白质和肽：最新进展综述。
Drug Deliv. 2013 Aug;20(6):237-46. doi: 10.3109/10717544.2013.819611.
7
Plant species and organ influence the structure and subcellular localization of recombinant glycoproteins.植物种类和器官影响重组糖蛋白的结构和亚细胞定位。
Plant Mol Biol. 2013 Sep;83(1-2):105-17. doi: 10.1007/s11103-013-0049-9. Epub 2013 Apr 4.
8
Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems.快速在瞬时植物表达系统中高水平生产具有广谱中和活性的 HIV 单克隆抗体。
PLoS One. 2013;8(3):e58724. doi: 10.1371/journal.pone.0058724. Epub 2013 Mar 22.
9
Optimizing the yield of recombinant pharmaceutical proteins in plants.优化植物中重组药物蛋白的产量。
Curr Pharm Des. 2013;19(31):5486-94. doi: 10.2174/1381612811319310004.
10
Commercial aspects of pharmaceutical protein production in plants.植物中药物蛋白生产的商业方面。
Curr Pharm Des. 2013;19(31):5471-7. doi: 10.2174/1381612811319310002.
Zotero 插件